These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 23011088)

  • 1. Scleroderma therapy: clinical overview of current trends and future perspective.
    Topal AA; Dhurat RS
    Rheumatol Int; 2013 Jan; 33(1):1-18. PubMed ID: 23011088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative therapies for systemic sclerosis.
    Ong VH; Denton CP
    Curr Opin Rheumatol; 2010 May; 22(3):264-72. PubMed ID: 20190640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of scleroderma.
    Gelber AC; Wigley FM
    Curr Opin Rheumatol; 1995 Nov; 7(6):551-9. PubMed ID: 8579978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in targeted therapies XII. Preface.
    Breedveld FC; Kalden JR; Smolen JS
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i1. PubMed ID: 21339210
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings of the XIIth International Symposium on Advances in Targeted Therapies. April 14-18, 2010.
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i1-122. PubMed ID: 21438187
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel treatment approaches to fibrosis in scleroderma.
    Distler J; Distler O
    Rheum Dis Clin North Am; 2008 Feb; 34(1):145-59; vii. PubMed ID: 18329537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile scleroderma.
    Athreya BH
    Curr Opin Rheumatol; 2002 Sep; 14(5):553-61. PubMed ID: 12192254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapies for systemic sclerosis.
    Denton CP; Black CM
    Springer Semin Immunopathol; 2001; 23(1-2):109-29. PubMed ID: 11455851
    [No Abstract]   [Full Text] [Related]  

  • 9. Towards a Better Classification and Novel Therapies Based on the Genetics of Systemic Sclerosis.
    Acosta-Herrera M; López-Isac E; Martín J
    Curr Rheumatol Rep; 2019 Jul; 21(9):44. PubMed ID: 31304568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current treatment options in systemic Sclerosis (Scleroderma).
    Stummvoll GH
    Acta Med Austriaca; 2002; 29(1):14-9. PubMed ID: 11899748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of systemic sclerosis].
    Meurer M; Rehberger P
    Hautarzt; 2007 Oct; 58(10):851-7. PubMed ID: 17849090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Old medications and new targeted therapies in systemic sclerosis.
    Nagaraja V; Denton CP; Khanna D
    Rheumatology (Oxford); 2015 Nov; 54(11):1944-53. PubMed ID: 25065013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis.
    Lin AT; Clements PJ; Furst DE
    Rheum Dis Clin North Am; 2003 May; 29(2):409-26. PubMed ID: 12841302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New pathogenic and therapeutic concepts in systemic sclerosis.
    Hügle T; Huigens CA; van Laar JM
    Arzneimittelforschung; 2009; 59(12):615-24. PubMed ID: 20108646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic sclerosis: hypothesis-driven treatment strategies.
    Charles C; Clements P; Furst DE
    Lancet; 2006 May; 367(9523):1683-91. PubMed ID: 16714190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in use of immunomodulatory agents--a rheumatology perspective.
    Her M; Kavanaugh A
    Nat Rev Gastroenterol Hepatol; 2015 Jun; 12(6):363-8. PubMed ID: 25895821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of scleroderma: an update.
    Sule SD; Wigley FM
    Expert Opin Investig Drugs; 2003 Mar; 12(3):471-82. PubMed ID: 12605568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative antifibrotic therapies in systemic sclerosis.
    Beyer C; Distler O; Distler JH
    Curr Opin Rheumatol; 2012 May; 24(3):274-80. PubMed ID: 22450392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical approach to the therapy of systemic sclerosis.
    Czirják L
    Z Rheumatol; 2004 Dec; 63(6):451-6. PubMed ID: 15605208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic sclerosis and localized scleroderma--current concepts and novel targets for therapy.
    Distler O; Cozzio A
    Semin Immunopathol; 2016 Jan; 38(1):87-95. PubMed ID: 26577237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.